Sotera Health Company

NASDAQ:SHCHealthcare · Medical - Diagnostics & Research

Mkt Cap$5.17B

Float265.58M

Shares O/S285.37M

Inst Own-

Dilution

-0.17%$18.10

AH Close$18.10+0.00%vs close

Mkt Cap$5.17B

Float265.58M

O/S285.37M

Inst Own-

Dilution

NASDAQ:SHC$18.10-0.17%

MCap$5.17B

Float265.58M

O/S285.37M

Inst Own-

Dilution

Historical Data

Date	Open	High	Low	Close	Volume

Key Metrics

Market Cap$5.17B

Enterprise Value--

P/E Ratio--

Est. Net Cash/Share--

Institutional Ownership--

based on 285.37M shares outstanding

SectorHealthcare

IndustryMedical - Diagnostics & Research

ExchangeNASDAQ

Country

IPO DateNov 20, 2020

Shares Outstanding285.37M

Float265.58M

Company Overview

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions.

The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses.

Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.

Leadership

Chistopher A. Simon

President and Chief Executive Officer, Haemonetics Corporation

Michael B. Petras, Jr.

Executive Chairman of the Board

Jonathan Lyons

Senior Vice President & Chief Financial Officer

Michael Rutz

President of Sterigenics U.S., LLC

Employees

3K+

Country

Sector

Healthcare

Website

soterahealth.com

Analyst Coverage

ConsensusBuy

Price Target

No price targets available

Ratings Distribution

BUY

HOLD

SELL

TOTAL12

Insider Trading

Insider	Title	Type	Shares	Value	Date
Petras Michael B. Jr.	Executive Chairman	Sale	294.5K	$5.45M	Aug 17, 2026
Petras Michael B. Jr.	Executive Chairman	Sale	850.0K	$15.73M	Aug 17, 2026
Rutz Michael P	President of Sterigenics	Sale	150.0K	$2.83M	Aug 7, 2026
Lyons Jonathan M.	Sr. Vice President, CFO	Automatic Sell	11.3K	$203.5K	Aug 5, 2026
SHADER ALTON	Chief Executive Officer	Grant/Award	375.9K	--	May 26, 2026
SHADER ALTON	Chief Executive Officer	Grant/Award	101.8K	--	May 26, 2026

Shareholders

Institutionalⓘ

(323)

1.0%

Insiderⓘ

(18)

5.6%

5%+ Owners

(1)

Unattributed (incl. retail)ⓘ

Insider1.0%

5%+ Beneficial5.6%

Top Shareholders

Name	Shares	%	Source
Sessa Capital IM, L.P.	27.1M	9.5%	13F
Darsana Capital Partners LP	27.0M	9.5%	13F
Darsana Capital Partners LP · also on 13F· may incl. warrants· filed Nov 2025	25.0M	8.8%	13G
BlackRock, Inc.	24.1M	8.5%	13F
Sculptor Capital LP	24.0M	8.4%	13F
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2026	23.8M	8.4%	13G
Sculptor Capital LP · also on 13F· may incl. warrants· filed Feb 2026	21.0M	7.4%	13G
Sessa Capital (Master), L.P. · may incl. warrants· reaffirmed 13F Aug 2026	15.9M	5.6%	13G
Sachem Head Capital Management LP	15.6M	5.5%	13F
VANGUARD CAPITAL MANAGEMENT LLC	12.2M	4.3%	13F